Clinical Trial Update: A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 ) [Phase 1]

View source ↗

Summary

A Phase 1 clinical study evaluating CT1190B (CT1190B-CG1101) in relapsed/refractory B-cell non-Hodgkin lymphoma; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• CT1190B

Snippet

Sponsor: Qian Wenbin | Conditions: B-Cell Non-Hodgkin Lymphoma | Phase 1 | Status: NOT_YET_RECRUITING